CGNH Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
<$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.00 - $0.01
Previous CloseN/A
Volume37.00
Average Volume (3M)0.00
Market Cap
$120.00
Enterprise ValueN/A
Total Cash (Recent Filing)$96.81K
Total Debt (Recent Filing)$378.50K
Price to Earnings (P/E)―
Beta-137.18
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding96,051,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CGNH FAQ
What was CardioGenics Holdings Inc.’s price range in the past 12 months?
CardioGenics Holdings Inc. lowest stock price was $0.00 and its highest was $0.01 in the past 12 months.
What is CardioGenics Holdings Inc.’s market cap?
CardioGenics Holdings Inc.’s market cap is $120.00.
When is CardioGenics Holdings Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were CardioGenics Holdings Inc.’s earnings last quarter?
Currently, no data Available
Is CardioGenics Holdings Inc. overvalued?
According to Wall Street analysts CardioGenics Holdings Inc.’s price is currently Overvalued.
Does CardioGenics Holdings Inc. pay dividends?
CardioGenics Holdings Inc. does not currently pay dividends.
What is CardioGenics Holdings Inc.’s EPS estimate?
CardioGenics Holdings Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CardioGenics Holdings Inc. have?
CardioGenics Holdings Inc. has 96,051,000 shares outstanding.
What happened to CardioGenics Holdings Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of CardioGenics Holdings Inc.?
Currently, no hedge funds are holding shares in CGNH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
CardioGenics Holdings Inc.
CardioGenics Holdings Inc. focuses on the creation and global distribution of diagnostic testing solutions within the in vitro diagnostics (IVD) sector, serving markets across the United States, Canada, Europe, and other international regions. A key offering is the QL Care Analyzer, an automated, self-contained, and portable point-of-care (POC) immunoassay device. This analyzer utilizes a unique, patented self-metering cartridge to perform immunoassay evaluations directly at the point of care. The company also provides a range of immunoassay panels specifically engineered to detect cardiac biomarkers in blood, which is vital for identifying heart attacks. Additionally, CardioGenics supplies paramagnetic beads, serving as crucial solid supports in heterogeneous immunoassay procedures for both clinical and research institutions. Established in 1997, the company was initially known as Jag Media Holdings, Inc. before officially changing its name to CardioGenics Holdings Inc. in 2009. Its corporate headquarters are situated in Mississauga, Canada.
Aethlon Medical
―
―
Acurx Pharmaceuticals
―
Dermata Therapeutics
―
Bluejay Diagnostics
―